|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Awala H, Gilson JP, Retoux R, Boullay P,
Goupil JM, Valtchev V and Mintova S: Template-free nanosized
faujasite-type zeolites. Nat Mater. 14:447–451. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fennell DA, Summers Y, Cadranel J, Benepal
T, Christoph DC, Lal R, Das M, Maxwell F, Visseren-Grul C and Ferry
D: Cisplatin in the modern era: The backbone of first-line
chemotherapy for non-small cell lung cancer. Cancer Treat Rev.
44:42–50. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Galluzzi L, Vitale I, Michels J, Brenner
C, Szabadkai G, Harel-Bellan A, Castedo M and Kroemer G: Systems
biology of cisplatin resistance: Past, present and future. Cell
Death Dis. 5:e12572014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mariño G, Niso-Santano M, Baehrecke EH and
Kroemer G: Self-consumption: The interplay of autophagy and
apoptosis. Nat Rev Mol Cell Biol. 15:81–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT,
Liu B and Bao JK: Programmed cell death pathways in cancer: A
review of apoptosis, autophagy and programmed necrosis. Cell
Prolif. 45:487–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD,
Adeli K, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rao S, Tortola L, Perlot T, Wirnsberger G,
Novatchkova M, Nitsch R, Sykacek P, Frank L, Schramek D, Komnenovic
V, et al: A dual role for autophagy in a murine model of lung
cancer. Nat Commun. 5:30562014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ren JH, He WS, Nong L, Zhu QY, Hu K, Zhang
RG, Huang LL, Zhu F and Wu G: Acquired cisplatin resistance in
human lung adenocarcinoma cells is associated with enhanced
autophagy. Cancer Biother Radiopharm. 25:75–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kroemer G and Levine B: Autophagic cell
death: The story of a misnomer. Nat Rev Mol Cell Biol. 9:1004–1010.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimizu S, Yoshida T, Tsujioka M and
Arakawa S: Autophagic cell death and cancer. Int J Mol Sci.
15:3145–3153. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng X and Kinsella TJ: Impact of
autophagy on chemotherapy and radiotherapy mediated tumor
cytotoxicity: ‘To Live or not to Live’. Front Oncol. 1:302011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang Y, Yan W, He X, Zhang L, Li C, Huang
H, Nace G, Geller DA, Lin J and Tsung A: miR-375 inhibits autophagy
and reduces viability of hepatocellular carcinoma cells under
hypoxic conditions. Gastroenterology. 143:177–187.e8. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang L, Cardinal JS, Pan P, Rosborough
BR, Chang Y, Yan W, Huang H, Billiar TR, Rosengart MR and Tsung A:
Splenocyte apoptosis and autophagy is mediated by interferon
regulatory factor 1 during murine endotoxemia. Shock. 37:511–517.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, Cardinal JS, Bahar R, Evankovich
J, Huang H, Nace G, Billiar TR, Rosengart MR, Pan P and Tsung A:
Interferon regulatory factor-1 regulates the autophagic response in
LPS-stimulated macrophages through nitric oxide. Mol Med.
18:201–208. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kitazumi I and Tsukahara M: Regulation of
DNA fragmentation: The role of caspases and phosphorylation. FEBS
J. 278:427–441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang ZJ, Chee CE, Huang S and Sinicrope
FA: The role of autophagy in cancer: Therapeutic implications. Mol
Cancer Ther. 10:1533–1541. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu K, Dunner K Jr and McConkey DJ:
Proteasome inhibitors activate autophagy as a cytoprotective
response in human prostate cancer cells. Oncogene. 29:451–462.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
de Castria TB, da Silva EM, Gois AF and
Riera R: Cisplatin versus carboplatin in combination with
third-generation drugs for advanced non-small cell lung cancer.
Cochrane Database Syst Rev: CD009256. 2013. View Article : Google Scholar
|
|
26
|
Claerhout S, Verschooten L, Van Kelst S,
De Vos R, Proby C, Agostinis P and Garmyn M: Concomitant inhibition
of AKT and autophagy is required for efficient cisplatin-induced
apoptosis of metastatic skin carcinoma. Int J Cancer.
127:2790–2803. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaminskyy VO, Piskunova T, Zborovskaya IB,
Tchevkina EM and Zhivotovsky B: Suppression of basal autophagy
reduces lung cancer cell proliferation and enhances
caspase-dependent and -independent apoptosis by stimulating ROS
formation. Autophagy. 8:1032–1044. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zou Y, Ling YH, Sironi J, Schwartz EL,
Perez-Soler R and Piperdi B: The autophagy inhibitor chloroquine
overcomes the innate resistance of wild-type EGFR non-small-cell
lung cancer cells to erlotinib. J Thorac Oncol. 8:693–702. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu F, Liu D, Yang Y and Zhao S: Effect of
autophagy inhibition on chemotherapy-induced apoptosis in A549 lung
cancer cells. Oncol Lett. 5:1261–1265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Janku F, McConkey DJ, Hong DS and Kurzrock
R: Autophagy as a target for anticancer therapy. Nat Rev Clin
Oncol. 8:528–539. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eisenberg-Lerner A, Bialik S, Simon HU and
Kimchi A: Life and death partners: Apoptosis, autophagy and the
cross-talk between them. Cell Death Differ. 16:966–975. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang YH, Wu YL, Tashiro S, Onodera S and
Ikejima T: Reactive oxygen species contribute to oridonin-induced
apoptosis and autophagy in human cervical carcinoma HeLa cells.
Acta Pharmacol Sin. 32:1266–1275. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Viola G, Bortolozzi R, Hamel E, Moro S,
Brun P, Castagliuolo I, Ferlin MG and Basso G: MG-2477, a new
tubulin inhibitor, induces autophagy through inhibition of the
Akt/mTOR pathway and delayed apoptosis in A549 cells. Biochem
Pharmacol. 83:16–26. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Driscoll JJ and Chowdhury RD: Molecular
crosstalk between the proteasome, aggresomes and autophagy:
Translational potential and clinical implications. Cancer Lett.
325:147–154. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu HM, Jiang ZF, Ding PS, Shao LJ and Liu
RY: Hypoxia-induced autophagy mediates cisplatin resistance in lung
cancer cells. Sci Rep. 5:122912015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Apel A, Herr I, Schwarz H, Rodemann HP and
Mayer A: Blocked autophagy sensitizes resistant carcinoma cells to
radiation therapy. Cancer Res. 68:1485–1494. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Livesey KM, Tang D, Zeh HJ and Lotze MT:
Autophagy inhibition in combination cancer treatment. Curr Opin
Investig Drugs. 10:1269–1279. 2009.PubMed/NCBI
|
|
38
|
Han W, Pan H, Chen Y, Sun J, Wang Y, Li J,
Ge W, Feng L, Lin X, Wang X, et al: EGFR tyrosine kinase inhibitors
activate autophagy as a cytoprotective response in human lung
cancer cells. PLoS One. 6:e186912011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang ZF, Shao LJ, Wang WM, Yan XB and Liu
RY: Decreased expression of Beclin-1 and LC3 in human lung cancer.
Mol Biol Rep. 39:259–267. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen Z, Li Y, Zhang C, Yi H, Wu C, Wang J,
Liu Y, Tan J and Wen J: Downregulation of Beclin 1 and impairment
of autophagy in a small population of colorectal cancer. Dig Dis
Sci. 58:2887–2894. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shen Y, Li DD, Wang LL, Deng R and Zhu XF:
Decreased expression of autophagy-related proteins in malignant
epithelial ovarian cancer. Autophagy. 4:1067–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou WH, Tang F, Xu J, Wu X, Yang SB, Feng
ZY, Ding YG, Wan XB, Guan Z, Li HG, et al: Low expression of Beclin
1, associated with high Bcl-xL, predicts a malignant phenotype and
poor prognosis of gastric cancer. Autophagy. 8:389–400. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang X, Du Z, Li L, Shi M and Yu Y: Beclin
1 and p62 expression in non-small cell lung cancer: Relation with
malignant behaviors and clinical outcome. Int J Clin Exp Pathol.
8:10644–10652. 2015.PubMed/NCBI
|
|
44
|
Scarlatti F, Maffei R, Beau I, Codogno P
and Ghidoni R: Role of non-canonical Beclin 1-independent autophagy
in cell death induced by resveratrol in human breast cancer cells.
Cell Death Differ. 15:1318–1329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chang SH, Minai-Tehrani A, Shin JY, Park
S, Kim JE, Yu KN, Hong SH, Hong CM, Lee KH, Beck GR Jr and Cho MH:
Beclin1-induced autophagy abrogates radioresistance of lung cancer
cells by suppressing osteopontin. J Radiat Res. 53:422–432. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Michaud M, Martins I, Sukkurwala AQ,
Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot
G, et al: Autophagy-dependent anticancer immune responses induced
by chemotherapeutic agents in mice. Science. 334:1573–1577. 2011.
View Article : Google Scholar : PubMed/NCBI
|
